Sulfated polysaccharide of
Animals
Antineoplastic Agents
/ pharmacology
Apoptosis
/ drug effects
Benzamides
/ pharmacology
Cell Cycle
/ drug effects
Cell Line, Tumor
Cell Movement
/ drug effects
Decapodiformes
Drug Resistance, Neoplasm
/ drug effects
Ink
Phosphorylation
/ drug effects
Piperazines
/ pharmacology
Polysaccharides
/ pharmacology
Proto-Oncogene Proteins c-akt
/ metabolism
Pyrazoles
/ pharmacology
Receptors, Fibroblast Growth Factor
/ antagonists & inhibitors
Urinary Bladder Neoplasms
/ drug therapy
AZD4547
FGFR therapy resistance
Sulfated polysaccharide of ink Sepiella maindroni
bladder cancer
xenograft
Journal
Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617
Informations de publication
Date de publication:
23 09 2019
23 09 2019
Historique:
received:
13
07
2019
accepted:
09
09
2019
pubmed:
24
9
2019
medline:
9
9
2020
entrez:
24
9
2019
Statut:
ppublish
Résumé
Rapid appearance of resistance to fibroblast growth factor receptor (FGFR) inhibitors hampers targeted regimens in bladder cancer. In the present study, we evaluated whether SIP-SII, a sulphated derivative of the polysaccharide in
Identifiants
pubmed: 31545294
doi: 10.18632/aging.102286
pii: 102286
pmc: PMC6782013
doi:
Substances chimiques
AZD4547
0
Antineoplastic Agents
0
Benzamides
0
Piperazines
0
Polysaccharides
0
Pyrazoles
0
Receptors, Fibroblast Growth Factor
0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7780-7795Références
Sci Transl Med. 2014 Jul 9;6(244):244ra91
pubmed: 25009231
Int J Biol Macromol. 2018 Feb;107(Pt A):349-362
pubmed: 28870748
Exp Ther Med. 2010 Sep;1(5):899-904
pubmed: 22993616
Invest New Drugs. 2017 Aug;35(4):451-462
pubmed: 28070720
Mol Cancer Ther. 2018 Oct;17(10):2217-2225
pubmed: 30045926
Tumour Biol. 2014 Jun;35(6):5401-7
pubmed: 24519067
Eur Urol. 2010 Sep;58(3):433-41
pubmed: 20646825
Int J Cancer. 2016 Mar 15;138(6):1494-505
pubmed: 26481559
Eur Urol. 2017 Jun;71(6):858-862
pubmed: 28108151
Br J Dis Chest. 1985 Oct;79(4):393-5
pubmed: 4052311
Mol Cancer Ther. 2013 Jul;12(7):1245-54
pubmed: 23657946
Biomed Pharmacother. 2008 Jun;62(5):297-302
pubmed: 18406565
Carbohydr Polym. 2013 Jan 2;91(1):403-9
pubmed: 23044150
J Urol. 2015 Jan;193(1):19-29
pubmed: 25158272
Dev Cell. 2014 Mar 31;28(6):697-710
pubmed: 24613396
Mol Cell Biol. 2002 Sep;22(17):6247-60
pubmed: 12167717
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
J Urol. 2012 Jul;188(1):276-86
pubmed: 22608749
J Pathol. 2007 Sep;213(1):91-8
pubmed: 17668422
Int J Clin Exp Pathol. 2015 Apr 01;8(4):3543-55
pubmed: 26097537
Cancer Discov. 2013 Jun;3(6):636-47
pubmed: 23558953
Cell. 2017 Oct 19;171(3):540-556.e25
pubmed: 28988769
Carcinogenesis. 2012 Apr;33(4):770-80
pubmed: 22287562
Biomed Pharmacother. 2017 Nov;95:95-102
pubmed: 28830011
Cancer Res. 2018 Oct 1;78(19):5668-5679
pubmed: 30115694
Eur Urol. 2017 Dec;72(6):960-961
pubmed: 28688612
J Vis Exp. 2014 Jun 01;(88):null
pubmed: 24962652
Cancer Treat Rev. 2016 Nov;50:208-216
pubmed: 27743530
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Br J Cancer. 2013 Sep 17;109(6):1586-92
pubmed: 23989949
Nat Rev Urol. 2015 Dec;12(12):681-94
pubmed: 26390971
Bladder Cancer. 2017 Apr 27;3(2):105-112
pubmed: 28516155
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593